Bill
HR 3826
HR 3826 expands Medicare and Medicaid coverage for diabetes self-management training, improving access and education for millions of individuals with diabetes.
The Expanding Access to Diabetes Self-Management Training Act of 2025 (HR 3826) aims to enhance the availability and accessibility of diabetes self-management training (DSMT) for individuals diagnosed with diabetes. The bill seeks to improve health outcomes for diabetic patients by ensuring they receive the necessary education and resources to manage their condition effectively.
Expansion of DSMT Services: The bill proposes to broaden the scope of diabetes self-management training services covered under Medicare and Medicaid. This includes increasing the number of hours of training available to patients.
Eligibility Criteria: HR 3826 aims to simplify the eligibility requirements for patients to access DSMT services, making it easier for more individuals to benefit from these programs.
Provider Qualifications: The legislation may also outline specific qualifications for healthcare providers offering DSMT, ensuring that patients receive high-quality education from certified professionals.
Increased Funding: The bill may include provisions for increased funding to support the implementation of expanded DSMT programs, ensuring that resources are available to meet the anticipated demand.
Individuals with Diabetes: The primary beneficiaries of this bill are individuals diagnosed with diabetes, who will gain improved access to essential self-management training.
Healthcare Providers: Providers of diabetes education and management services will be impacted by the new requirements and potential funding opportunities.
Medicare and Medicaid Programs: The bill will affect how these federal programs reimburse for diabetes self-management training services, potentially leading to changes in policy and funding allocations.
Introduced: The bill was introduced in the House of Representatives on June 6, 2025.
Committee Referrals: Upon introduction, HR 3826 was referred to the Committee on Energy and Commerce and the Committee on Ways and Means for further consideration. The timeline for these committees to review the bill will be determined by the Speaker of the House.
Cosponsors: The bill has garnered support from several cosponsors, including notable representatives such as Eleanor Holmes Norton, Suzan K. DelBene, Debbie Wasserman Schultz, and Gus M. Bilirakis, with Kim Schrier serving as the primary sponsor.
HR 3826 has a companion bill, S 1925, which is being considered in the Senate. This parallel effort may facilitate a more comprehensive approach to diabetes management across both chambers of Congress.
This summary provides an overview of HR 3826, highlighting its purpose, key provisions, affected parties, and legislative process. The bill represents a significant step towards improving diabetes management and education for millions of Americans living with this chronic condition.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
